SAFETY AND EFFICACY OF COMBINATION THERAPY OF INTERFERON ΑLPHA-2 AND RUXOLITINIB IN POLYCYTHEMIA VERA AND LOW-/INTERMEDIATE-1-RISK MYELOFIBROSIS – A ONE YEAR FOLLOW-UP UPDATE OF A PHASE II STUDY

Stine Ulrik Mikkelsen; Lasse Kjær; Mads Emil Bjørn; Trine Alma Knudsen; Anders Lindholm Sørensen; Vibe Skov; Christen Bertel Lykkegaard Andersen; Ole Weiss Bjerrum; Nana Brochmann Mortensen; Daniel El Fassi; Torben A Kruse; Thomas Stauffer Larsen; Hans Torben Mourits-Andersen; Claus Henrik Nielsen; Niels  Pallisgaard; Mads Thomassen; Hans Carl  Hasselbalch

SAFETY AND EFFICACY OF COMBINATION THERAPY OF INTERFERON ΑLPHA-2 AND RUXOLITINIB IN POLYCYTHEMIA VERA AND LOW-/INTERMEDIATE-1-RISK MYELOFIBROSIS – A ONE YEAR FOLLOW-UP UPDATE OF A PHASE II STUDY

Stine Ulrik Mikkelsen, Lasse Kjær, Mads Emil Bjørn, Trine Alma Knudsen, Anders Lindholm Sørensen, Vibe Skov, Christen Bertel Lykkegaard Andersen, Ole Weiss Bjerrum, Nana Brochmann Mortensen, Daniel El Fassi, Torben A Kruse, Thomas Stauffer Larsen, Hans Torben Mourits-Andersen, Claus Henrik Nielsen, Niels Pallisgaard, Mads Thomassen, Hans Carl Hasselbalch

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Article number	PF620
Journal	EHA Learning Center
Volume	2018
Publication status	Published - Jun 2018
Event	European Hematology Association 23rd congress EHA 2018 - Stockholm , Sweden Duration: 14. Jun 2018 → 17. Jun 2018

Conference

Conference	European Hematology Association 23rd congress EHA 2018
Country/Territory	Sweden
City	Stockholm
Period	14/06/2018 → 17/06/2018

Documents & Links

http://learningcenter.ehaweb.org/eha/2018/stockholm/215880/stine.mikkelsen.safety.and.efficacy.of.combination.therapy.of.interferon.htmlLicence: Unspecified

Cite this

Mikkelsen, S. U., Kjær, L., Bjørn, M. E., Knudsen, T. A., Sørensen, A. L., Skov, V., Andersen, C. B. L., Weiss Bjerrum, O., Brochmann Mortensen, N., El Fassi, D., Kruse, T. A., Larsen, T. S., Mourits-Andersen, H. T., Nielsen, C. H., Pallisgaard, N., Thomassen, M., & Hasselbalch, H. C. (2018). SAFETY AND EFFICACY OF COMBINATION THERAPY OF INTERFERON ΑLPHA-2 AND RUXOLITINIB IN POLYCYTHEMIA VERA AND LOW-/INTERMEDIATE-1-RISK MYELOFIBROSIS – A ONE YEAR FOLLOW-UP UPDATE OF A PHASE II STUDY. EHA Learning Center, 2018, Article PF620. http://learningcenter.ehaweb.org/eha/2018/stockholm/215880/stine.mikkelsen.safety.and.efficacy.of.combination.therapy.of.interferon.html

@article{3616619859af4e85b714eccf6cff2e89,

title = "SAFETY AND EFFICACY OF COMBINATION THERAPY OF INTERFERON ΑLPHA-2 AND RUXOLITINIB IN POLYCYTHEMIA VERA AND LOW-/INTERMEDIATE-1-RISK MYELOFIBROSIS – A ONE YEAR FOLLOW-UP UPDATE OF A PHASE II STUDY",

author = "Mikkelsen, {Stine Ulrik} and Lasse Kj{\ae}r and Bj{\o}rn, {Mads Emil} and Knudsen, {Trine Alma} and S{\o}rensen, {Anders Lindholm} and Vibe Skov and Andersen, {Christen Bertel Lykkegaard} and {Weiss Bjerrum}, Ole and {Brochmann Mortensen}, Nana and {El Fassi}, Daniel and Kruse, {Torben A} and Larsen, {Thomas Stauffer} and Mourits-Andersen, {Hans Torben} and Nielsen, {Claus Henrik} and Niels Pallisgaard and Mads Thomassen and Hasselbalch, {Hans Carl}",

year = "2018",

month = jun,

language = "English",

volume = "2018",

journal = "EHA Learning Center",

note = "European Hematology Association 23rd congress EHA 2018 ; Conference date: 14-06-2018 Through 17-06-2018",

}

Mikkelsen, SU, Kjær, L, Bjørn, ME, Knudsen, TA, Sørensen, AL, Skov, V, Andersen, CBL, Weiss Bjerrum, O, Brochmann Mortensen, N, El Fassi, D, Kruse, TA, Larsen, TS, Mourits-Andersen, HT, Nielsen, CH, Pallisgaard, N, Thomassen, M & Hasselbalch, HC 2018, 'SAFETY AND EFFICACY OF COMBINATION THERAPY OF INTERFERON ΑLPHA-2 AND RUXOLITINIB IN POLYCYTHEMIA VERA AND LOW-/INTERMEDIATE-1-RISK MYELOFIBROSIS – A ONE YEAR FOLLOW-UP UPDATE OF A PHASE II STUDY', EHA Learning Center, vol. 2018, PF620. <http://learningcenter.ehaweb.org/eha/2018/stockholm/215880/stine.mikkelsen.safety.and.efficacy.of.combination.therapy.of.interferon.html>

SAFETY AND EFFICACY OF COMBINATION THERAPY OF INTERFERON ΑLPHA-2 AND RUXOLITINIB IN POLYCYTHEMIA VERA AND LOW-/INTERMEDIATE-1-RISK MYELOFIBROSIS – A ONE YEAR FOLLOW-UP UPDATE OF A PHASE II STUDY. / Mikkelsen, Stine Ulrik; Kjær, Lasse; Bjørn, Mads Emil et al.
In: EHA Learning Center, Vol. 2018, PF620, 06.2018.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - SAFETY AND EFFICACY OF COMBINATION THERAPY OF INTERFERON ΑLPHA-2 AND RUXOLITINIB IN POLYCYTHEMIA VERA AND LOW-/INTERMEDIATE-1-RISK MYELOFIBROSIS – A ONE YEAR FOLLOW-UP UPDATE OF A PHASE II STUDY

AU - Mikkelsen, Stine Ulrik

AU - Kjær, Lasse

AU - Bjørn, Mads Emil

AU - Knudsen, Trine Alma

AU - Sørensen, Anders Lindholm

AU - Skov, Vibe

AU - Andersen, Christen Bertel Lykkegaard

AU - Weiss Bjerrum, Ole

AU - Brochmann Mortensen, Nana

AU - El Fassi, Daniel

AU - Kruse, Torben A

AU - Larsen, Thomas Stauffer

AU - Mourits-Andersen, Hans Torben

AU - Nielsen, Claus Henrik

AU - Pallisgaard, Niels

AU - Thomassen, Mads

AU - Hasselbalch, Hans Carl

PY - 2018/6

Y1 - 2018/6

M3 - Conference abstract in journal

VL - 2018

JO - EHA Learning Center

JF - EHA Learning Center

M1 - PF620

T2 - European Hematology Association 23rd congress EHA 2018

Y2 - 14 June 2018 through 17 June 2018

ER -